Pier Capital’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-65,526
| Closed | -$5.47M | – | 131 |
|
|
2024
Q4 | $5.47M | Sell |
65,526
-34
| -0.1% | -$2.84K | 0.78% | 77 |
|
|
2024
Q3 | $4.8M | Buy |
65,560
+1,056
| +2% | +$77.3K | 0.68% | 83 |
|
|
2024
Q2 | $4.42M | Buy |
64,504
+10,050
| +18% | +$688K | 0.66% | 79 |
|
|
2024
Q1 | $3.77M | Sell |
54,454
-596
| -1% | -$41.2K | 0.52% | 87 |
|
|
2023
Q4 | $3.94M | Sell |
55,050
-94,079
| -63% | -$6.74M | 0.56% | 83 |
|
|
2023
Q3 | $7.77M | Sell |
149,129
-1,664
| -1% | -$86.7K | 1.25% | 25 |
|
|
2023
Q2 | $9.55M | Buy |
150,793
+2,897
| +2% | +$183K | 1.37% | 20 |
|
|
2023
Q1 | $8.01M | Buy |
147,896
+5,155
| +4% | +$279K | 1.21% | 27 |
|
|
2022
Q4 | $7.55M | Sell |
142,741
-1,297
| -0.9% | -$68.6K | 1.24% | 36 |
|
|
2022
Q3 | $6.7M | Buy |
144,038
+27,392
| +23% | +$1.27M | 1.15% | 43 |
|
|
2022
Q2 | $6.66M | Buy |
+116,646
| New | +$6.66M | 1.14% | 45 |
|
|
2021
Q1 | – | Sell |
-190,833
| Closed | -$6.07M | – | 129 |
|
|
2020
Q4 | $6.07M | Buy |
+190,833
| New | +$6.07M | 0.64% | 85 |
|
|
2015
Q3 | – | Sell |
-257,256
| Closed | -$8.22M | – | 133 |
|
|
2015
Q2 | $8.22M | Buy |
+257,256
| New | +$8.22M | 1.18% | 11 |
|